Author Correction: Evolution from adherent to suspension: systems biology of HEK293 cell line development

Affiliations

Magdalena Malm: KTH ‑ School of Engineering Sciences in Chemistry, Biotechnology, and Health, Dept. of Protein Science, Royal Institute of Technology
Rasool Saghaleyni: Department of Biology and Biological Engineering, Chalmers University of Technology
Magnus Lundqvist: KTH ‑ School of Engineering Sciences in Chemistry, Biotechnology, and Health, Dept. of Protein Science, Royal Institute of Technology
Marco Giudici: KTH ‑ School of Engineering Sciences in Chemistry, Biotechnology, and Health, Dept. of Protein Science, Royal Institute of Technology
Veronique Chotteau: KTH ‑ School of Engineering Sciences in Chemistry, Biotechnology, and Health, Dept. of Protein Science, Royal Institute of Technology
Ray Field: Biopharmaceutical Development, BioPharmaceuticals R&D, AstraZeneca
Paul G. Varley: Biopharmaceutical Development, BioPharmaceuticals R&D, AstraZeneca
Diane Hatton: Biopharmaceutical Development, BioPharmaceuticals R&D, AstraZeneca
Luigi Grassi: Biopharmaceutical Development, BioPharmaceuticals R&D, AstraZeneca
Thomas Svensson: Department of Biology and Biological Engineering, Chalmers University of Technology
Jens Nielsen: Department of Biology and Biological Engineering, Chalmers University of Technology
Johan Rockberg: KTH ‑ School of Engineering Sciences in Chemistry, Biotechnology, and Health, Dept. of Protein Science, Royal Institute of Technology

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.